Mary L Schapiro
CIK 1192486 · last filed 2026-07-29
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
DUK price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
1735 K STREET NW
WASHINGTON, DC 20006
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| MS | Director | 40,842 | $187.56 | $7.66M | -$212.1K | 1 | 2026-07-29 |
| MWD | Director | 41,842 | — | — | $0 | 13 | 2026-06-02 |
| CVS | Director | 11,843 | $89.01 | $1.05M | $0 | 16 | 2024-11-25 |
| GE | Director | 1,425 | $337.91 | $481.5K | $190.5K | 20 | 2018-04-02 |
| DUK | Director | 11,608 | $128.94 | $1.50M | -$345.6K | 6 | 2009-01-20 |
| Mondelez International, Inc. (KFT) Delisted | Director | 16,752 | — | — | $0 | 23 | 2009-01-20 |
| Mondelez International, Inc. (KFT.WD) Delisted | Director | 28,384 | — | — | $0 | 3 | 2008-08-04 |
Recent Filings · Page 2 of 9
83 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-05-19 | CVS | Grant (A) | — | $0 | EDGAR |
| 2022-12-02 | MWD | Grant (A) | +511 | $47.5K | EDGAR |
| 2022-11-21 | CVS | Grant (A) | — | $0 | EDGAR |
| 2022-06-03 | MWD | Grant (A) | +2,944 | $0 | EDGAR |
| 2022-05-13 | CVS | Grant (A) | — | $0 | EDGAR |
| 2021-11-19 | CVS | Grant (A) | +417 | $38.7K | EDGAR |
| 2021-06-03 | MWD | Grant (A) | +2,702 | $0 | EDGAR |
| 2021-05-14 | CVS | Grant (A) | +459 | $38.7K | EDGAR |
| 2020-11-20 | CVS | Grant (A) | +2,336 | $155.0K | EDGAR |
| 2020-06-03 | MWD | Grant (A) | +6,649 | $47.5K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.